Characterization of growth performance of F1 hybrid CB6F1 C57-ras transgenic mouse model
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [14]
  • | | | |
  • Comments
    Abstract:

    Objective To obtain the basic growth parameters of a self-established F1 hybrid CB6F1 C57-ras transgenic mouse model, and to provide basic information for commercialization of this mouse model. Methods F1 hybrid mice (CB6F1) were produced by crossing C57-ras heterozygous transgenic (c-Ha-ras+/-) male mice and wild-type BALB/cJ female mice. The average litter size, weaning rate, sex ratio, growth performance and C57-ras transgenic positive rate were recorded and analyzed. Results The average litter size was eight, weaning rate was 90%, and sex ratio was approximately in accordance with prediction. The average body weight of newborn mice was 1.73±0.05 g. The average body weight of 10-week old c-Ha-ras transgenic female and male mice in CB6F1 background was 24.38±1.74 g and 29.42±1.72g, respectively, which had a significant difference (P<0.01). The c-Ha-ras transgenic positive rate was 46.9%. which was in accordance with genetic rules. Conclusions The F1 hybrid mice (CB6F1) produced by crossing C57-ras heterozygous transgenic (c-Ha-ras +/-) male mice and wild-type BALB/cJ female mice show normal growth performance and development characteristics, and it can be used for large-scale commercial supply.

    Reference
    [1] 田小芸, 恽时锋, 郭联庆, 等. Nrf2 基因敲除小鼠的繁育及生长发育的生物学特性 [J].中国比较医学杂志, 2009, 19(2): 50-52.
    [2] 范昌发, 岳秉飞, 王军志, 等. 含有人源原癌基因c-Ha-ras的转基因小鼠的制作方法及其用途[P]. ZL 2008 1 0101666.0, 2013.9.4.
    [3] 周舒雅, 左琴, 刘甦苏, 等. C57-ras转基因小鼠模型的建立 [J]. 药物分析杂志, 2013, 33(11): 1928-1934.
    [4] 范昌发, 李波, 王军志, 等. 遗传修饰致癌性动物模型与药物临床前安全性评价 [D]. 北方实验动物科技年会, 2009, 66-68.
    [5] Nielsen LL, Gurnani M, Tyler RD. Evaluation of the wap-ras transgenic mouse as a model system for testing anticancer drugs [J]. Cancer Res, 1992, 52: 733-3738.
    [6] Saitoh A, Kimura M, Takahashi R, et al. Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes [J]. Oncogene, 1990, 5(8): 1195-1197.
    [7] Urano1 K, Tamaoki N, Nomura T. Establishing a laboratory animal model from a transgenic animal: RasH2 mice as a model for carcinogenicity studies in regulatory science [J]. Vet Pathol, 2012, 49(1): 16-23.
    [8] ICH Sl B. International conference on harmonization ICH S1B. (1997) [M/OL]. Guidance for industry S1B testing for carcinogenicity of pharmaceuticals. http:///www.fda.gov/cder/guidance/index. htm.
    [9] 刘甦苏, 周舒雅, 高正琴, 等. c-Ha-ras在转基因小鼠模型C57-ras各组织中的表达谱分析 [J]. 生物技术通讯, 2013, 24(5): 636-640.
    [10] 吕建军, 刘甦苏, 左琴, 等. C57-ras转基因小鼠模型的MNU验证实验 [J]. 药物分析杂志, 2013, 33(11): 1935-1940.
    [11] 张俭, 黄星群, 刘建军. BALB/c小鼠繁殖性能的观察及分析 [J]. 四川动物, 2006,25(1): 179-181.
    [12] 席晓霞, 秦天达, 吴润, 等. SPF级BALB/c C57BL/6小鼠繁殖性能及生长发育的比较研究 [J]. 畜牧兽医杂志, 2009, 28(6): 11-12.
    [13] 吴清洪, 顾为望, 张嘉宁, 等. SPF 级C57BLP6J 小鼠生长发育和繁殖性能指标的测定[J].中国比较医学杂志, 2006, 16(10): 606-607.
    [14] 张洪, 鲍波. 浅谈国内BALB/c小鼠及KM小鼠的基本生物学特性 [J]. 中国实用医药, 2010, 5(3): 252-254.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation
Share
Article Metrics
  • Abstract:2811
  • PDF: 1608
  • HTML: 0
  • Cited by: 0
History
  • Revised:January 21,2015
  • Online: April 29,2015
Article QR Code